2022 World Stem Cell Summit
6-11 June 2022
Members of our Cell, Tissue, and Gene Therapies team presented three cross-cutting and dynamic panels at the combined 17th annual World Stem Cell Summit (WSCS) and Wake Forest Institute for ...
21st Annual Pharmaceutical and Medical Device Ethics and Compliance Congress
4-6 November 2020
Gejaa Gobena and Thomas Beimers spoke at the virtual 21st Annual Pharmaceutical and Medical Device Ethics and Compliance Congress.
HHS anti-kickback and Stark proposed rules: Impact on value-based care and longstanding regulatory hurdles
14 November 2019 | 11:00 AM - 12:00 PM (EST)
CMS and OIG proposed wide-ranging protections for value-based arrangements and provided guidance on a number of regulatory challenges under the AKS and Stark Law. On November 14, join us...
Proposed AKS rewrite on drug rebates: The impact and challenges ahead
22 February 2019 | 12:00 PM - 1:00 PM (EST)
The Trump Administration recently proposed what is arguably the most sweeping change to the regulatory safe harbors for the federal health care anti-kickback statute in decades. The...
